1. Genetic variation determines VEGF-A plasma levels in cancer patients
   Federico Innocenti et al, 2018, Scientific Reports CrossRef
2. The Anti-VEGF(R) Drug Discovery Legacy: Improving Attrition Rates by Breaking the Vicious Cycle of Angiogenesis in Cancer
   Domenico Ribatti et al, 2021, Cancers CrossRef
3. Ramucirumab Plus Docetaxel for Patients with Non-small cell Lung Cancer with Brain Metastases: A Multicenter, Open-Label Single-Arm Phase II Trial
   Keiko Tanimura et al, 2023, The Oncologist CrossRef
4. Prognostic factors for survival with bevacizumab-based therapy in colorectal cancer patients: a systematic review and pooled analysis of 11,585 patients
   Fausto Petrelli et al, 2015, Medical Oncology CrossRef
5. Tumour vasculature immaturity, oxidative damage and systemic inflammation stratify survival of colorectal cancer patients on bevacizumab treatment
   Sinead A. Noonan et al, 2018, Oncotarget CrossRef
6. The cancer angiogenesis co-culture assay: In vitro quantification of the angiogenic potential of tumoroids
   Sarah Line Bring Truelsen et al, 2021, PLOS ONE CrossRef
7. Targeted Therapies For Intestinal Tumorigenesis
   E. Gabriela Chiorean et al, 2015, Intestinal Tumorigenesis CrossRef
8. Predictive Biomarkers in Metastatic Colorectal Cancer: A Systematic Review
   Juan Ruiz-Bañobre et al, 2019, JCO Precision Oncology CrossRef
9. Plasma Angiogenic Factors as Predictors of the Efficacy of Second-line Chemotherapy Combined with Angiogenesis Inhibitors in Metastatic Colorectal Cancer: Results From the GI-SCREEN CRC-Ukit Study
   Satoshi Yuki et al, 2024, Clinical Colorectal Cancer CrossRef
10. Bloch surface wave label-free and fluorescence platform for the detection of VEGF biomarker in biological matrices
    Riccardo Rizzo et al, 2018, Sensors and Actuators B: Chemical CrossRef
11. Divergent Impact of Breast Cancer Laterality on Clinicopathological, Angiogenic, and Hemostatic Profiles: A Potential Role of Tumor Localization in Future Outcomes
    Ruszkowska-Ciastek Barbara et al, 2020, Journal of Clinical Medicine CrossRef
12. VEGF-A promotes the motility of human melanoma cells through the VEGFR1–PI3K/Akt signaling pathway
    Koichi Koizumi et al, 2022, In Vitro Cellular & Developmental Biology - Animal CrossRef
13. Advances and perspectives of colorectal cancer stem cell vaccine
    Mei Guo et al, 2015, Biomedicine & Pharmacotherapy CrossRef
14. Markers to Predict the Efficacy of Bevacizumab in the Treatment of Metastatic Colorectal Cancer
    Umut Varol et al, 2014, Tumori Journal CrossRef
15. Profiles of Endoglin and Vascular Endothelial Growth Factor Based on Staging and Histological Grading of Colorectal Cancer and Their Relationship with Bevacizumab Therapy
    Rahmawati Minhajat et al, 2021, Journal of Coloproctology CrossRef
16. Targeting angiogenesis in oncology, ophthalmology and beyond
    Yihai Cao et al, 2023, Nature Reviews Drug Discovery CrossRef
17. Expression of pro-angiogenic factors as potential biomarkers in experimental models of colon cancer
    Simona Delle Monache et al, 2020, Journal of Cancer Research and Clinical Oncology CrossRef